Interferon y and Tumor Necrosis Factor Have a Role in Tumor Regressions Mediated by Murine CD8+ Tumor-infiltrating Lymphocytes

We have investigated the mechanisms whereby adoptively transferred murine CD8+ lymphocytes mediate tumor regressions. Noncytolytic, CD8+ tumor-infiltrating lymphocytes (TIL) eradicated established lung tumors in irradiated mice. Many cytolytic and noncytolytic CD8+ TIL cultures specifically secreted interferon y (IFN-y) and tumor necrosis factor when stimulated with tumor cells in vitro. The effectiveness ofTIL when adoptively transferred to micebearing micrometastases correlated better with their ability to specifically secrete lymphokines than with their cytotoxicity in vitro. In 14 of 15 tests, therapeutically effective TIL specifically secreted IFN-y in vitro, whereas only 1 of 11 ineffective TIL specifically secreted IFN-y. In contrast, only 8 of 15 therapeutically effective TIL were cytolytic. Antibodies to TNF inhibited the effectiveness of two adoptively transferred TIL cultures . In five experiments, antibodies to IFN-y abrogated the ability of four different CD8+ TIL cultures to mediate tumor regressions, indicating that secretion of IFN-y is an essential part of the mechanism of action of TIL.

[1]  H. Fujiwara,et al.  The role of tumor-specific Lyt-1+2− T cells in eradicating tumor cells in vivo , 1987, Cancer Immunology, Immunotherapy.

[2]  N. Na.  The Surgery Branch of the National Cancer Institute , 1994 .

[3]  T. Issekutz.  Effects of six different cytokines on lymphocyte adherence to microvascular endothelium and in vivo lymphocyte migration in the rat. , 1990, Journal of immunology.

[4]  S. Rosenberg,et al.  Unique murine tumor-associated antigens identified by tumor infiltrating lymphocytes. , 1990, Journal of immunology.

[5]  T. Gajewski,et al.  Anti-proliferative effect of IFN-gamma in immune regulation. IV. Murine CTL clones produce IL-3 and GM-CSF, the activity of which is masked by the inhibitory action of secreted IFN-gamma. , 1990, Journal of immunology.

[6]  H. Langstein,et al.  Passive immunization against tumor necrosis factor partially abrogates interleukin 2 toxicity , 1989, The Journal of experimental medicine.

[7]  K. Okuno,et al.  Specific adoptive immunotherapy. , 1989, Progress in clinical and biological research.

[8]  G. Forni,et al.  Obligatory role of IFN-gamma in induction of lymphokine-activated and T lymphocyte killer activity, but not in boosting of natural cytotoxicity. , 1988, Journal of immunology.

[9]  S. Rosenberg,et al.  In vivo antitumor activity of tumor-infiltrating lymphocytes expanded in recombinant interleukin-2. , 1987, Journal of the National Cancer Institute.

[10]  P. Greenberg.  Therapy of murine leukemia with cyclophosphamide and immune Lyt-2+ cells: cytolytic T cells can mediate eradication of disseminated leukemia. , 1986, Journal of immunology.

[11]  S. Rosenberg,et al.  Adoptive immunotherapy of newly induced murine sarcomas. , 1985, Cancer research.

[12]  S. Rosenberg,et al.  Eradication of a disseminated syngeneic mouse lymphoma by systemic adoptive transfer of immune lymphocytes and its dependence upon a host component(s). , 1985, Cancer research.

[13]  I. Fidler,et al.  Nonselective destruction of murine neoplastic cells by syngeneic tumoricidal macrophages. , 1985, Cancer research.

[14]  P. Comoglio,et al.  Characterization of T lymphocytes mediating in vivo protection against RSV‐induced murine sarcomas , 1983, International journal of cancer.

[15]  I. Weissman,et al.  Protection against syngeneic lymphoma by a long-lived cytotoxic T-cell clone. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Y. L. Lin,et al.  Biological properties of an influenza A virus-specific killer T cell clone. Inhibition of virus replication in vivo and induction of delayed- type hypersensitivity reactions , 1981, The Journal of experimental medicine.

[17]  M. Meltzer.  Macrophage activation for tumor cytotoxicity: characterization of priming and trigger signals during lymphokine activation. , 1981, Journal of immunology.

[18]  C. McArthur,et al.  Demonstration in vitro of cytotoxic T cells with apparent specificity toward tumor-specific transplantation antigens on chemically induced tumors. , 1979, Journal of immunology.

[19]  E. Fernandez-cruz,et al.  In vivo elimination by specific effector cells of an established syngeneic rat moloney virus-induced sarcoma. , 1979, Journal of immunology.

[20]  J. R. Oehler,et al.  Evidence for long-lasting tumor immunity in a syngeneic rat lymphoma model: correlation of in vitro findings with in vivo observations. , 1979, Journal of the National Cancer Institute.

[21]  E. Kedar,et al.  In vitro induction of cell-mediated immunity to murine leukemia cells. II. cytotoxic activity in vitro and tumor-neutralizing capacity in vivo of anti-leukemia cytotoxic lymphocytes generated in macrocultures. , 1977, Journal of immunological methods.

[22]  C. Pasternak.  Normal and transformed cells in vitro , 1977 .

[23]  R. Anderson,et al.  Ionizing radiation and the immune response. , 1976, Advances in immunology.

[24]  M. Röllinghoff,et al.  IN VITRO INDUCTION OF TUMOR-SPECIFIC IMMUNITY , 1973, The Journal of experimental medicine.